Daiichi Life Insurance Co. Ltd. Makes New Investment in Corteva, Inc. $CTVA

Daiichi Life Insurance Co. Ltd. acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 26,582 shares of the company’s stock, valued at approximately $2,251,000.

Several other institutional investors have also added to or reduced their stakes in the business. Commerce Bank purchased a new stake in shares of Corteva during the second quarter valued at $5,208,000. Northwestern Mutual Wealth Management Co. bought a new position in Corteva during the 2nd quarter valued at about $4,381,000. Evolve Private Wealth LLC purchased a new stake in shares of Corteva during the 2nd quarter valued at about $341,000. Varma Mutual Pension Insurance Co bought a new stake in shares of Corteva in the second quarter worth approximately $15,699,000. Finally, Westpac Banking Corp purchased a new position in shares of Corteva during the second quarter valued at approximately $437,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CTVA shares. Morgan Stanley raised their target price on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. BMO Capital Markets raised their price target on Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, August 3rd. Jefferies Financial Group upped their price objective on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. Finally, CICC Research upped their price target on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and an average price target of $91.50.

Corteva Trading Up 0.1%

NYSE:CTVA opened at $81.84 on Monday. The firm has a market capitalization of $54.60 billion, a price-to-earnings ratio of 54.20, a price-to-earnings-growth ratio of 2.51 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The business has a fifty day moving average price of $82.13 and a 200-day moving average price of $80.26. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.Corteva’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio is currently 47.68%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.